Screener
Madrigal Pharmaceuticals, Inc. MDGL Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from Madrigal Pharmaceuticals, Inc.’s reported figures.
The source filing: Madrigal Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026. Open the filing →
- Filed
- May 6, 2026, 9:04 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-030947
FAQ
- What is Madrigal Pharmaceuticals, Inc.'s free cash flow?
- Madrigal Pharmaceuticals, Inc. (MDGL) reported free cash flow of -$171.28M in Q1 2026.
- How has Madrigal Pharmaceuticals, Inc.'s free cash flow changed year-over-year?
- Madrigal Pharmaceuticals, Inc.'s free cash flow decreased by 92.7% year-over-year, from -$88.89M to -$171.28M.
- What is the long-term trend for Madrigal Pharmaceuticals, Inc.'s free cash flow?
- Over 3 years (2021 to 2024), Madrigal Pharmaceuticals, Inc.'s free cash flow has grown at a 35.4% compound annual growth rate (CAGR), from -$184.13M to -$457.03M.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.
Ask your AI about Madrigal Pharmaceuticals, Inc.'s free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude